Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study (Q37984704)

26 August 2017

title

Risk of preeclampsia in HIV-positive pregnant women receiving HAART: a matched cohort study (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

Talar Boyajian

1

1 reference

26 August 2017

Prakesh S Shah

series ordinal

2

1 reference

26 August 2017

Kellie E Murphy

series ordinal

3

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Journal of Obstetrics and Gynaecology Canada

26 August 2017

published in

1 reference

26 August 2017

volume

34

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

136-141

1 reference

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Pre-eclampsia, antiretroviral therapy, and immune reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Obstetric and newborn outcomes in a cohort of HIV-infected pregnant women: a report of the women and infants transmission study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Preeclampsia and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Combination antiretroviral therapy and duration of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Increased rates of preterm delivery are associated with the initiation of highly active antiretrovial therapy during pregnancy: a single-center cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

No relation between in-utero exposure to HAART and intrauterine growth retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

A new and improved population-based Canadian reference for birth weight for gestational age.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Pre-eclampsia: Is the immune maladaptation hypothesis still standing? An epidemiological update.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Race and ethnic disparities in fetal mortality, preterm birth, and infant mortality in the United States: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

Racial/ethnic disparities in obstetric outcomes and care: prevalence and determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935156-8

7 January 2021

10.1016/S1701-2163(16)35156-8

Identifiers

DOI

0 references

1 reference